Eduard van Gelderen
SVP and Chief Investment Officer @ PSP Investments
Montréal, Canada
Eduard van Gelderen is a Series A investor at PSP Investments in Montréal focused on Medical and Health Care. Eduard van Gelderen - SVP and Chief Investment Officer @ Public Sector Pension Investment Board
- Total investments:
- 4
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Eduard van Gelderen invests in
Stages Eduard van Gelderen invests in
Countries Eduard van Gelderen invests in
Investment Focus
Industry
- Medical 1 (25%)
- Health Care 1 (25%)
- Biotechnology 1 (25%)
Stage
- Series A 1 (25%)
- Series B 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Valo Health
|
Valo Health, LLC (Valo) is a technology company that is using human-centric data and machine learning-anchored computation to transform the drug discovery and development process. By integrating data across the drug development lifecycle, the discovery and development of life-changing treatments can be accelerated, with the potential to reducecost, time, and failure rate. The company's Opal Computational Platform™, a fully integrated, componentized, end-to-end drug development platform, offers a unique approach to therapeutic development, that enables Valo to advance a robust pipeline of candidates across cardiovascular disease, oncology, and neurodegeneration. | $190M / Series B / Jan 11, 2021 | |
|
Valo Health
|
Valo Health, LLC (Valo) is a technology company that is using human-centric data and machine learning-anchored computation to transform the drug discovery and development process. By integrating data across the drug development lifecycle, the discovery and development of life-changing treatments can be accelerated, with the potential to reducecost, time, and failure rate. The company's Opal Computational Platform™, a fully integrated, componentized, end-to-end drug development platform, offers a unique approach to therapeutic development, that enables Valo to advance a robust pipeline of candidates across cardiovascular disease, oncology, and neurodegeneration. | $190M / Series B / Jan 11, 2021 | |
|
Valo Health
|
Valo Health, LLC (Valo) is a technology company that is using human-centric data and machine learning-anchored computation to transform the drug discovery and development process. By integrating data across the drug development lifecycle, the discovery and development of life-changing treatments can be accelerated, with the potential to reducecost, time, and failure rate. The company's Opal Computational Platform™, a fully integrated, componentized, end-to-end drug development platform, offers a unique approach to therapeutic development, that enables Valo to advance a robust pipeline of candidates across cardiovascular disease, oncology, and neurodegeneration. | $100M / Series A / Jul 01, 2019 | |
|
Valo Health
|
Valo Health, LLC (Valo) is a technology company that is using human-centric data and machine learning-anchored computation to transform the drug discovery and development process. By integrating data across the drug development lifecycle, the discovery and development of life-changing treatments can be accelerated, with the potential to reducecost, time, and failure rate. The company's Opal Computational Platform™, a fully integrated, componentized, end-to-end drug development platform, offers a unique approach to therapeutic development, that enables Valo to advance a robust pipeline of candidates across cardiovascular disease, oncology, and neurodegeneration. | $100M / Series A / Jul 01, 2019 |
Co-Investors
About PSP Investments
PSP Investments is one of Canada’s largest pension investment managers, with $116.8 billion of assets under management as at March 31, 2016. We invest funds for the pension plans of the Public Service, the Canadian Armed Forces, the Royal Canadian Mounted Police and the Reserve Force.Our skilled and dedicated team of more than 600 professionalsmanages a diversified global portfolio including stocks, bonds and other fixed-income securities, and investments in Private Equity, Real Estate, Infrastructure, Natural Resources and Private Debt.Our business offices are in Montreal, New York, London and Luxembourg. Our head office is in Ottawa.
PSP Investments Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Annie Sorich
TitleSenior Director, Strategy and Business Planning
|
|||
David Court
Director
|
|||
|
Eduard van Gelderen
SVP and Chief Investment Officer
|
|||
Loic Jule
Managing Director - Global Investment Partnerships Portfolio
|
|||
|
Nicholas Lenicheck
Senior Director, Capital Markets Alternatives
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Eduard van Gelderen invest in?
Eduard van Gelderen invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Eduard van Gelderen last invest?
The most recent investment recorded for Eduard van Gelderen closed in Jan 2021. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
